Other languages Charmacy Pharmaceutical Co., Ltd.

Equities

2289

CNE1000023D6

Market Closed - Hong Kong S.E. Other stock markets 04:08:17 2024-05-17 am EDT			5-day change	1st Jan Change
14.4 ^HKD	+7.78%		+3.60%	+11.11%

Mar. 28	Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 18	Charmacy Pharmaceutical’s Profit to Drop by 45% in 2023	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Charmacy Pharmaceutical 2023 Profit Declines on Lower Asset Disposal Gains	Apr. 01
Charmacy Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 10 July 2024	Mar. 28
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28
Charmacy Pharmaceutical’s Profit to Drop by 45% in 2023	Mar. 18
Charmacy Pharmaceutical Meets Minimum Public Float Norms	23-09-04
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-27
Charmacy Pharmaceutical Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2022, Payable on 31 July 2023	23-06-05
Charmacy Pharmaceutical Co., Ltd. Announces Board Changes	23-05-31
Charmacy Pharmaceutical Co., Ltd. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on July 31, 2023	23-05-25
Charmacy Pharmaceutical's Controlling Shareholder Signs Letter of Commitment for Director Appointment; Shares Climb 6%	23-04-19
Charmacy Pharmaceutical Co., Ltd. Announces Resignation of Executives	23-04-18
Charmacy Pharmaceutical Co., Ltd. Recommends Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 20 July 2023	23-03-31
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31
Charmacy Pharmaceutical Renews Loan Provision Deal with Controlling Shareholder	23-03-03
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders.	23-02-09
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 9% of stake in Charmacy Pharmaceutical Co., Ltd. from Yao Chuanglong.	23-01-16
Charmacy Pharmaceutical Forecasts Increase in January-November Net Profit	22-12-20
Charmacy Pharmaceutical Co., Ltd. Provides Financial Guidance for the 11 Months Ended 30 November 2022	22-12-20
Charmacy Pharmaceutical to Surrender Land Use Right on Property in China for $22.3 Million	22-10-12
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Charmacy Pharmaceutical Co., Ltd.

Equities

2289

CNE1000023D6

Other languages

Filters